Back to Portfolio
NIFTY 50
·

Stock & MF Portfolio

+30.1%
XIRR
+44.4%
TOTAL
Eternal Limited
14.4%▲ +126%

Blinkit was growing faster than food delivery ever did. The market priced a food app. I bought a quick commerce company hiding inside one.

SGBJUN30
13.8%▲ +65.6%

Gold appreciation was the thesis. The 2.5% annual interest was just free money on top. Better than physical gold in every measurable way.

Mahindra & Mahindra
12.2%▲ +89.6%

Best SUVs in the segment, strong fundamentals, and an EV lineup that actually shipped. Most auto companies promise an EV future. M&M delivered one.

Interglobe Aviation
12.2%▲ +66%

India is massively underpenetrated on air travel. IndiGo has 60%+ market share and no serious domestic competitor left standing. A market structure bet more than a company bet.

BSE Limited
8.3%▲ +20%

Every retail investor who opens a Zerodha or Groww account eventually touches BSE infrastructure. Bet that the retail explosion was structural, not a pandemic fluke. And it wasn't.

Ceat Limited
6.8%▲ +66.3%

Every vehicle on Indian roads needs new tyres every few years regardless of the economy. The replacement market is massive, recurring, and largely ignored. CEAT has been quietly taking share.

Raymond Group
6.4%▲ +15%

Real estate arm sitting on prime land parcels across Mumbai with strong execution on residential launches. Apparel funds operations while realty does the heavy lifting on value creation.

Reliance Industries
6.2%▲ +5.29%

Two businesses that would each be Nifty 50 companies on their own. Jio owns India's digital infrastructure. The refinery is one of the largest in the world. The stock underperformed but the businesses didn't.

Adani Enterprises
5.7%▲ +13%

The incubator for everything Adani touches next. Airports, green hydrogen, data centres, roads — all pass through here before becoming standalone listed companies. Buying early access to India's infrastructure pipeline.

Sun Pharma
4%▼ −3.4%

India is quietly becoming the diabetes and obesity capital of the world. Sun Pharma's GL0034 (Utreglutide) is a homegrown long-acting GLP-1 agonist sitting on a market that hasn't even formed yet. Holding through the red.

Tata Motors
2.7%▼ −26%

They make good cars. Thesis didn't work out.

Others
4%▲ +8%
+14.97%
XIRR
+13.84%
TOTAL
HDFC Nifty 50 Index
28.8%▲ +10.6%
Motilal Oswal Midcap
26.5%▲ +19.3%
Motilal Nifty Microcap 25
11.3%▲ +11.3%
ICICI Pru US Bluechip
12.14%▲ +17.9%
ICICI Pru Smallcap
10.4%▲ +10.9%